Syncom Formulation (India) Ltd

SYNCOMF

Company Profile

  • Business description

    Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

  • Contact

    207, Saket Nagar
    Near Saket Club
    IndoreMP452018
    IND

    T: +91 7312560458

    https://www.sfil.in

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    2,122

Stocks News & Analysis

stocks

Cheapest ASX member of our Best Idea’s list

This share is trading at the lowest price to fair value of the 14 companies on the list.
stocks

We remove our Moat Rating from ASX listed share

Despite a surging share price a weakening competitive position causes a reassessment of our view.
stocks

Best sustainable companies to own in 2026

We believe these companies’ strong ESG management practices give them a long-term advantage.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,996.9078.80-0.87%
CAC 408,211.5016.290.20%
DAX 4024,868.69329.351.34%
Dow JONES (US)48,977.18594.791.23%
FTSE 10010,004.5753.430.54%
HKSE26,705.41358.171.36%
NASDAQ23,395.82160.190.69%
Nikkei 22552,518.08685.281.32%
NZX 50 Index13,663.5876.350.56%
S&P 5006,902.0543.580.64%
S&P/ASX 2008,682.8088.50-1.01%
SSE Composite Index4,083.6760.251.50%

Market Movers